Hatchtech Pty Ltd

FDA's Center for Drug Evaluation and Research (CDER) approved its fourth novel agent of 2017, Valeant Pharmaceuticals International Inc. 's Siliq , in an otherwise quiet week for new product actio

For parents head lice is one of the scourges of winter. Now that snow storms have hit many parts of the country leaving kids stuck inside, sponsors could have an increased incentive to ponder a draft

IN VITRO DIAGNOSTICS Mergers & Acquisitions Erba Diagnostics Mannheim GMBH Lumora Ltd. Clinical testing products developer ERBA Diagnostics Mannheim GMBH bought private molecular diagnostics firm

Allergan PLC 's antipsychotic Vraylar became the 25th novel drug approved by FDA's Center for Drug Evaluation and Research in 2015. New submissions were plentiful, including a first-line claim for